what does the federal hemp ban mean for smoke shops?

on november 12, 2025, president trump signed h.r. 5371 — the continuing appropriations, agriculture, legislative branch, military construction and veterans affairs, and extensions act, 2026. buried inside that government funding package was section 781, a provision that fundamentally rewrites the federal definition of hemp under the agricultural marketing act. effective november 12, 2026, most of the $28 billion intoxicating hemp market — delta-8 thc, thca flower, hemp-derived edibles and beverages, hhc, thc-o, delta-10 — becomes federally illegal. for smoke shops, this represents the largest regulatory shift since the 2018 farm bill created the category in the first place. this guide explains what section 781 actually does, what survives the change, and what smoke shop operators can do during the twelve-month transition window.

august 2026 update

the effective date is, for the first time, genuinely in play — but only by thirty days, and only if the house acts. here is what happened between late july and august 13.

the senate voted to delay most of the ban by one month. on august 8, the senate passed h.r. 6500, its continuing resolution funding the government through december 11, by a 90-6 vote. section 2019 of that bill pushes most of section 781’s restrictions from november 12 to december 11, 2026. an amendment by senator ted budd to strip the delay was tabled 61-32. two caveats matter. first, the delay carves out synthetic cannabinoids — compounds not capable of being naturally produced by the plant, which covers converted delta-8, still become controlled substances on november 12. second, this is not law. the house passed its own funding bill in june without the delay and is not expected to take up the senate version until september. plan around november 12; treat december 11 as upside.

the travis county trial never happened. our july update said the dshs consumable-hemp case went to trial on july 27. it did not — the trial date was vacated because the state’s interlocutory appeal is still pending before the fifteenth court of appeals, and there is no verdict and no timeline for one. the temporary injunction was lifted june 5, so dshs’s march 31 rules remain enforceable while the appeal plays out.

texas’s delta-8 ban took effect july 31, and a federal judge declined to block it. the reinstated schedule I listing covering delta-8, delta-10, thcp and similar isomers became enforceable july 31. the same day, a manufacturer, an austin retailer, and a consumer sued in federal court in galveston arguing the ban conflicts with the 2018 farm bill. on august 9, u.s. district judge jeffrey brown denied their emergency restraining order; a preliminary-injunction motion is pending. texas shops dumped inventory and cut staff hours ahead of the deadline, and the owner of one plaintiff shop reported several closures in the days around it. there is still no reliable national closure count.

the fda lists remain unpublished. as of august 13, the cannabinoid lists due in february still do not exist. two new bills — the lawful hemp protection act (h.r. 9830, barr and craig, july 22) and the beverage regulatory parity act (van duyne and landsman, august 10) — would replace parts of the ban with regulation. neither has moved out of committee.

july 2026 update

section 781 is still on track. the effective date remains november 12, 2026, and nothing that happened between may and july changed it. here is what did happen.

the fda still has not published its cannabinoid lists. the statute gave the agency 90 days — a deadline of roughly february 10, 2026 — to publish lists of naturally occurring cannabinoids, thc-class cannabinoids, and similar-effect cannabinoids, plus a clearer definition of “container.” in may 2026, the congressional research service confirmed the guidance had not been published, and in june 2026 marijuana moment reported that the fda had given no timeline. until those lists exist, operators cannot know exactly which compounds fall on which side of the line.

the white house asked congress to soften or delay the ban. in june 2026, omb director russell vought sent house speaker mike johnson a letter posted on whitehouse.gov requesting that congress revise federal hemp regulation “to ensure the fair treatment of hemp products” consistent with a pending amendment to h.r. 8646, “or, at minimum, an extension of implementation” of section 781. this followed president trump’s april 2026 social media post urging congress to protect access to full-spectrum cbd. a request is not a law. congress has not acted on either option.

the repeal and delay bills have not moved. as of july 2026, h.r. 6209 (repeal) and h.r. 7024 (delay) remain in committee. in april 2026, a farm bill amendment to delay the ban by one year was withdrawn before a vote, and an amendment to speed the ban up was kept off the floor.

states kept tightening ahead of the federal date. in tennessee, the state’s thca sales ban took full effect on july 1, 2026, moving hemp oversight to the alcoholic beverage commission. in texas, a travis county judge blocked the state’s smokable hemp rules in may, an appeals court reinstated them in early june, and the case was set for trial on july 27 — but the trial was vacated pending the state’s interlocutory appeal. (correction, august 13: an earlier version of this update said the case went to trial on july 27. it did not; see the august update above.) separately, texas reinstated its 2021 controlled-substance definitions — making delta-8 and other non-delta-9 thc isomers enforceable as controlled substances with civil penalties starting july 31, 2026 (texas register notice) — a distinct regulatory track from the dshs rules still on appeal. as of july 2026, no federal court challenge to section 781 itself has been reported.

the retail damage is showing up first in texas. shops there told the texas tribune in may that smokable hemp is 43 to 50 percent of sales, and some are cutting hours, closing locations, or discounting inventory to raise cash. there is no reliable national closure count yet.

plan around november 12, 2026. treat any delay as upside, not a base case.

what section 781 actually changes

section 781 amends the agricultural marketing act of 1946 — the same statute the 2018 farm bill used to remove hemp from the controlled substances act. the 2018 framework defined hemp as cannabis sativa l. with a delta-9 thc concentration of no more than 0.3 percent on a dry weight basis. that definition ignored other cannabinoids, which is what created the so-called “farm bill loophole” — the legal opening that allowed delta-8 thc, thca flower, hexahydrocannabinol (hhc), thc-o, and similar compounds to be sold as federally legal hemp despite having intoxicating effects substantially similar to marijuana.

according to perkins coie’s legal analysis of the bill (source), section 781 makes three principal changes to existing federal law. first, it replaces the delta-9-only threshold with a “total thc” standard that explicitly includes thca and delta-8. second, it imposes a per-container ceiling of 0.4 milligrams of total thc on finished consumable hemp products. third, it expressly excludes synthetic or converted cannabinoids — including delta-8 created through cbd isomerization — from the federal hemp definition entirely.

the practical consequence is significant. as harris sliwoski’s canna law blog summarizes, products that exceed the new total-thc limit will no longer qualify as “hemp” under federal law and will therefore fall back into schedule i controlled substance status under the controlled substances act (source). industry economists and legal analysts estimate that approximately 95 percent of currently marketed hemp-derived cannabinoid products will become non-compliant when the new definition takes effect (source).

the new definition of hemp

under section 781, “hemp” is redefined as the plant cannabis sativa l. with a total tetrahydrocannabinols concentration — including thca and delta-8 thc — of not more than 0.3 percent on a dry weight basis. this is a substantive change from the 2018 standard in two ways:

total thc instead of delta-9 only. previously, thca flower testing at 25 percent thca but less than 0.3 percent delta-9 thc qualified as legal hemp because thca was not counted toward the threshold. under the new definition, that same flower would test at approximately 22 percent total thc — far above the 0.3 percent limit — and would be reclassified as marijuana under the controlled substances act.

0.4 milligrams per container cap on finished products. for context, hemp-derived thc edibles and beverages currently on the market typically contain between 2.5 and 10 milligrams of delta-9 thc per unit, substantially above the new threshold (source). this cap effectively eliminates the consumer market for hemp-derived thc beverages, gummies, vapes, and tinctures as currently formulated.

synthetic and converted cannabinoid exclusion. section 781 explicitly excludes from the hemp definition any cannabinoid that is “not capable of being naturally produced by cannabis sativa l.” this targets delta-8 thc produced through chemical conversion of cbd — which represents the vast majority of delta-8 products currently sold — and similar synthetic cannabinoids like hhc and thc-o.

the fda is required to publish lists of naturally occurring cannabinoids within 90 days of enactment, which puts the deadline for that guidance at approximately february 10, 2026 (source).

what becomes illegal on november 12, 2026

based on the statutory language and the legal analyses published by perkins coie, frier levitt, harris sliwoski, and others, the following product categories become federally illegal on november 12, 2026:

delta-8 thc in any form, when produced through cbd isomerization (which is how nearly all commercially sold delta-8 is manufactured). vapes, gummies, tinctures, distillate, and flower sprayed or infused with delta-8 all fall outside the new hemp definition.

thca flower and pre-rolls. raw hemp flower with high thca content currently dominates the “legal weed” category in non-recreational states. because thca counts toward total thc under the new definition, virtually all commercial thca flower exceeds the 0.3 percent threshold and becomes a controlled substance.

delta-10 thc, hhc, thc-o, thc-p, thcv-o, and other synthetic or converted cannabinoids. these are excluded categorically by the synthetic cannabinoid provision.

hemp-derived thc beverages. the 0.4 mg per container cap effectively eliminates the existing market. industry analysts at clark hill plc note that this provision alone disrupts a billion-dollar trade in thc-infused beverages that has become a meaningful revenue source for craft breweries and alcohol distributors during a period of declining traditional alcohol sales (source).

hemp-derived thc edibles, tinctures, and topicals containing more than 0.4 mg total thc per container. this includes most currently marketed gummies, chocolates, capsules, and sublingual products.

hemp-derived vapes containing any of the above cannabinoids above the threshold.

what stays legal

section 781 does not eliminate hemp as a category — it narrows it. the following products remain legal under federal law after november 12, 2026:

non-intoxicating cbd products that meet the new total-thc threshold and the 0.4 mg per-container cap. broad-spectrum and isolate cbd products generally remain compliant.

industrial hemp for fiber, grain, textile, building material, and biofuel applications. the industrial hemp market — valued at $5.49 billion globally in 2023 and projected to reach $16.82 billion by 2030 — is unaffected by section 781 (source).

hemp seeds for human consumption — hempseed oil, hemp protein, hemp hearts — provided they meet the new total-thc standard.

non-cannabis tobacco and nicotine products — cigarettes, cigars, pipe tobacco, smokeless tobacco, traditional vape e-liquids, nicotine pouches. these are regulated under separate fda authority and are unaffected by section 781.

kratom and kava — both are unrelated to cannabis and not subject to hemp regulation.

state-licensed marijuana in states with adult-use or medical cannabis programs. shops that hold marijuana licenses can continue selling thc products through those channels.

glass, accessories, and ancillary smoke shop categories — pipes, water pipes, rolling papers, lighters, grinders, scales — all unaffected.

the timeline

• november 12, 2025 — h.r. 5371 signed into law by president trump
• february 10, 2026 (approximate) — fda required to publish lists of naturally occurring cannabinoids per the 90-day window
• march-october 2026 — industry transition period; many operators reformulate, exit, or pivot
• november 12, 2026 — section 781 takes effect; new definition of hemp becomes federal law; non-compliant products become schedule i controlled substances

industry-wide impact

the financial scale of section 781’s impact is unusually large for a single regulatory action. according to mjbizdaily (source), the spending package effectively outlaws “nearly all the estimated $28.3 billion u.s. hemp industry.” secondary analyses from clark hill plc and ainvest place the figure at $28.4 billion, with approximately 300,000 jobs at risk across cultivation, extraction, manufacturing, distribution, and retail (source).

states will also lose approximately $1.5 billion annually in tax revenue from intoxicating hemp products, according to mcdonald hopkins (source). some states with heavy hemp-derived thc economies face particularly acute impact: texas industry analysis projects up to 40,000 job losses and $7.5 billion in economic impact statewide (source).

the policy alliance that produced section 781 was unusual. as mjbizdaily reported, the bill drew support from traditional cannabis operators (who view hemp-derived thc as unregulated competition), anti-legalization advocates, law enforcement, public health groups, and major alcohol lobbies. notably, senator mitch mcconnell (r-ky.) — the original author of the 2018 farm bill that created the hemp category — championed the section 781 provision that effectively closes the loophole he opened.

in october 2025, a bipartisan coalition of 39 state and territory attorneys general sent a letter to congress urging passage of language closing the farm bill loophole (source). this multi-state pressure was a significant factor in section 781’s inclusion in the appropriations package.

what this means for smoke shops specifically

for independent smoke shops — the audience for this guide — section 781 presents three operational realities that need to be planned for now, not in late 2026.

revenue concentration risk. depending on the shop’s mix, intoxicating hemp products may account for anywhere from 20 to 60 percent of monthly gross revenue. shops that built heavily on delta-8 vapes, thca flower, and thc beverages over the past three years are facing the most concentrated exposure. shops that maintained a more diversified inventory across glass, traditional tobacco, kratom, kava, and cbd will see narrower revenue impact.

inventory liability. product purchased before november 12, 2026 that exceeds the new thc limit becomes a controlled substance on that date. retailers cannot legally sell or even possess such products after the effective date without dea licensure. this creates a hard incentive to sell through current intoxicating hemp inventory before the deadline, or to negotiate returns with suppliers — many of whom face the same problem upstream.

margin compression during transition. as shops compete to sell through pre-ban inventory, prices on intoxicating hemp products will likely fall. simultaneously, replacement categories — non-intoxicating cbd, kratom, kava, expanded glass and accessories, vape hardware, traditional tobacco — have generally lower per-unit gross margin than thca flower or premium delta-8 products. the math problem is straightforward: revenue from a banned category will need to be replaced by higher-volume sales of lower-margin categories.

state-licensed cannabis is not a universal pivot path. in states with adult-use or medical cannabis programs, some smoke shops will pursue state cannabis licensure as a pivot. but state cannabis licensure is expensive (often hundreds of thousands of dollars in fees, build-out, and compliance costs), competitive, and not available in roughly half of u.s. states. for most independent smoke shops, the pivot is into non-intoxicating product categories rather than into the regulated cannabis market.

shops adapting to the transition typically need working capital for one or more of: bulk purchase of replacement inventory at favorable wholesale terms, increased payroll during expanded merchandising and category resets, marketing to reposition the shop’s identity post-pivot, and bridge cash flow during the months when intoxicating hemp revenue falls before replacement categories scale up.

state-by-state interaction

section 781 changes federal law, but states retain authority to impose more restrictive (or more permissive) requirements on hemp products within their borders. several scenarios will play out in parallel:

states that already banned delta-8 and intoxicating hemp. roughly 20 states had already moved to ban or severely restrict delta-8, hhc, and similar cannabinoids before section 781 was enacted. these include alaska, colorado, delaware, hawaii, idaho, iowa, kansas, louisiana, massachusetts, michigan, minnesota, mississippi, montana, nevada, new hampshire, new york, north dakota, oregon, rhode island, utah, vermont, virginia, washington, and west virginia. in these states, the federal ban has minimal additional retail impact because the products were already off shelves (source).

states with active hemp-derived thc programs. california and connecticut had established frameworks regulating delta-8 within their existing cannabis structures; minnesota, kentucky, and others had implemented age-gated retail programs; tennessee moved from an age-gated program to a full thca sales ban effective july 1, 2026, under alcoholic beverage commission oversight. these state frameworks may continue to operate under state law, but the products sold through them must still comply with the new federal hemp definition or face controlled-substance classification federally.

states where delta-8 was broadly legal under hemp framework. alabama, arkansas, florida, georgia, illinois, indiana, maine, maryland, missouri, nebraska, new jersey, new mexico, north carolina, ohio, oklahoma, pennsylvania, south carolina, south dakota, tennessee, texas, wisconsin, and wyoming had previously allowed delta-8 sales under their hemp programs. these states will see the most acute retail impact from section 781.

texas is a particularly complex case. texas has a major hemp-derived thc economy estimated at $7.5 billion. the texas department of state health services rule banning smokable thca hemp takes effect march 31, 2026, ahead of the federal deadline. texas also passed hb 700 in 2025, a commercial financing disclosure law that requires sales-based financing providers and brokers to register with the office of consumer credit commissioner by december 31, 2026. shops in texas face concurrent state-level restriction, federal restriction, and tightening commercial financing oversight all within the same window.

pending legislation

section 781’s enforcement deadline is not certain to hold. as of april 2026, two bills are pending that would either repeal or delay the provision:

h.r. 6209 — the american hemp protection act of 2025. introduced by representative nancy mace (r-sc) on november 17, 2025 and co-sponsored by representatives massie, lofgren (d-ca), and baird (r-in), this bill would strike section 781 in its entirety and restore the 2018 farm bill definition of hemp. industry groups have criticized the bill for proposing no regulatory framework to replace the repealed provision, which has limited its momentum.

h.r. 7024 — the hemp planting predictability act. introduced by representative baird (r-in) on january 13, 2026, this bill would extend the section 781 effective date from november 12, 2026 to november 12, 2029, giving the industry three additional years to pivot or seek further legislative changes. the bill has gained 36 bipartisan co-sponsors but had not advanced out of committee as of april 2026 (source).

the cannabinoid safety and regulation act. a third bill, which would replace the section 781 ban with a federal regulatory framework including thc limits per serving, age-gating, and testing requirements, has also not advanced.

operators should plan around the current november 12, 2026 enforcement date, treating any legislative delay as an upside scenario rather than a base case. the house agriculture committee advanced the 2026 farm bill in march 2026 without including any section 781 delay provision, which is a meaningful signal that the deadline is likely to hold.

funding the pivot

for smoke shop owners navigating the next twelve months, working capital availability becomes a central operational concern. traditional bank lending remains largely unavailable to smoke shops regardless of revenue history — banks treat the entire category as too high-risk for standard small business loans. sba 7(a) loans are technically available but rarely funded for shops with any tobacco or hemp-derived thc revenue.

what remains accessible:

merchant cash advances (mcas). funders purchase a percentage of future receivables in exchange for a lump sum advance. approval is based on three months of bank statements rather than credit score. typical funded amounts range from $10,000 to $500,000, with decisions in 24 to 72 hours. eight to twelve specialty funders nationally will approve smoke shops, including shops with stacked positions or recent declines.

equipment financing. if the pivot involves new equipment — display cases, refrigeration for non-intoxicating beverages, vape hardware, point-of-sale upgrades — equipment financing companies will often approve shops that wouldn’t qualify for unsecured working capital.

lines of credit through alternative lenders. harder to obtain in the tobacco-adjacent category but available to shops with two or more years of consistent operating history.

new york, california, virginia, utah, connecticut, florida, georgia, kansas, missouri, louisiana, and texas all have commercial financing disclosure laws (cfdls) in effect or pending that require funders to provide standardized disclosures — including estimated apr, total cost of capital, payment schedule, and broker compensation — at the time an offer is presented (source). this is a positive development for borrowers. shops should expect to receive a written disclosure document with any commercial financing offer in those states; if a broker or funder does not provide one, that is a regulatory red flag.

frequently asked questions

sources

• perkins coie — shutdown legislation brings new hemp rules (legal analysis of h.r. 5371 section 781)
• frier levitt — the redefinition of “hemp” under federal law (detailed regulatory analysis)
• harris sliwoski canna law blog — notes on the federal prohibition of intoxicating hemp
• mcdonald hopkins — hemp industry changes under new spending bill
• mjbizdaily — $28 billion industry outlawed as congress passes hemp thc ban
• clark hill plc — a billion-dollar trade on the brink
• hbk cpa — federal hemp ban business guide
• troutman pepper regulatory oversight — congress narrows federal definition of hemp
• npr — a year from now hemp shops could disappear under a new federal ban
• venable llp — state commercial financing disclosure laws: recent developments
• congress.gov — h.r. 5371 full text

related guides

• how merchant cash advances work for smoke shops
• mca vs. line of credit: which makes sense for your shop?
• reading your bank statements the way a funder reads them

state-specific resources

• smoke shop funding in california
• smoke shop funding in texas
• smoke shop funding in florida
• smoke shop funding in new york
• see all states →

this guide is general information, not legal or financial advice. specific compliance obligations vary by state, product, and business. consult qualified counsel for current advice. mellow is an information and referral website, not a lender, and does not guarantee a match or offer.